cilazaprilat has been researched along with Myocardial Ischemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Komamura, K; Kosaka, H; Minamino, T; Mori, H; Node, K; Shinozaki, Y | 1 |
Becker, BF; Gerlach, E; Habazettl, H; Kupatt, C; Messmer, K; Weber, C; Zahler, S | 1 |
Asanuma, H; Hori, M; Kitakaze, M; Kosaka, H; Kuzuya, T; Minamino, T; Node, K; Ueda, Y | 1 |
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
Becker, BF; Kupatt, C; Zahler, S | 1 |
5 other study(ies) available for cilazaprilat and Myocardial Ischemia
Article | Year |
---|---|
Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cilazapril; Coronary Circulation; Dogs; Myocardial Ischemia; Nitric Oxide | 1995 |
ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Adhesion; Cilazapril; Coronary Vessels; Flow Cytometry; Guinea Pigs; Macrophage-1 Antigen; Male; Microscopy, Fluorescence; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Perfusion | 1997 |
Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cilazapril; Coronary Circulation; Dogs; Imidazoles; Imidazolidines; Myocardial Ischemia; Nitric Oxide; Peptidyl-Dipeptidase A | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
ACE-inhibition attenuates cardiac cell damage and preserves release of NO in the postischemic heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide | 1999 |